<?xml version="1.0" encoding="UTF-8"?>
<ref id="B9-pharmaceutics-13-00238">
 <label>9.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wright</surname>
    <given-names>D.J.</given-names>
   </name>
   <name>
    <surname>Potter</surname>
    <given-names>J.F.</given-names>
   </name>
   <name>
    <surname>Clark</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Blyth</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Maskrey</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Mencarelli</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Wicks</surname>
    <given-names>S.O.</given-names>
   </name>
   <name>
    <surname>Craig</surname>
    <given-names>D.Q.M.</given-names>
   </name>
  </person-group>
  <article-title>Administration of Aspirin Tablets Using a Novel Gel-Based Swallowing Aid: An Open-Label Randomised Controlled Cross-over Trial</article-title>
  <source>BMJ Innov.</source>
  <year>2019</year>
  <volume>5</volume>
  <fpage>113</fpage>
  <lpage>119</lpage>
  <pub-id pub-id-type="doi">10.1136/bmjinnov-2018-000293</pub-id>
  <?supplied-pmid 32038883?>
  <pub-id pub-id-type="pmid">32038883</pub-id>
 </element-citation>
</ref>
